National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Mycosis Fungoides and the Sézary Syndrome Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 05/06/2008



General Information About Mycosis Fungoides and the Sézary Syndrome






Stages of Mycosis Fungoides and the Sézary Syndrome







Recurrent Mycosis Fungoides and the Sézary Syndrome






Treatment Option Overview






Treatment Options by Stage






Treatment Options for Recurrent Mycosis Fungoides and the Sézary Syndrome






To Learn More About Mycosis Fungoides and the Sézary Syndrome






Get More Information From NCI






Changes to This Summary (05/06/2008)






About PDQ



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Recurrent Mycosis Fungoides and the Sézary Syndrome

Recurrent mycosis fungoides and the Sézary syndrome are cancers that have recurred (come back) after they have been treated. The cancer may come back in the skin or in other parts of the body.

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov